Why Omega Healthcare Will Have a Healthy 2013

Updated

Based on the aggregated intelligence of 180,000-plus investors participating in Motley Fool CAPS, the Fool's free investing community, health care facility REIT Omega Healthcare Investors has earned a coveted five-star ranking.

With that in mind, let's take a closer look at Omega Healthcare and see what CAPS investors are saying about the stock right now.

Omega Healthcare facts

Headquarters (founded)

Hunt Valley, Md. (1992)

Market Cap

$2.7 billion

Industry

REIT

Trailing-12-Month Revenue

$331.8 million

Management

CEO C. Taylor Pickett
CFO Robert Stephenson

Return on Equity (average, past 3 years)

7.6%

Cash/Debt

$7.0 million / $1.6 billion

Dividend Yield

7.5%

Competitors

HCP
Healthcare Realty Trust
Ventas


Sources: S&P Capital IQ and Motley Fool CAPS.

On CAPS, 96% of the 249 members who have rated Omega Healthcare believe the stock will outperform the S&P 500 going forward.

Earlier this week, one of those Fools, AOverlord, succinctly summed up the bull case for our community:

With an aging and longer living population in America, this stock should remain a steady performer. I don't [expect] the stock price to [rise] substantially, but the price won't fall much either, and the dividend should continue to rise.

If you want market-topping returns, you need to put together the best portfolio you can. Owning exceptional stocks is a surefire way to secure your financial future. Of course, despite its five-star rating, Omega Healthcare may not be your top choice.

If that's the case, we've compiled a special free report for investors called "The 3 Dow Stocks Dividend Investors Need," which uncovers a few other juicy income opportunities. The report is 100% free, but it won't be around forever, so click here to access it now.

Want to see how well (or not so well) the stocks in this series are performing? Follow the TrackPoisedTo CAPS account.

The article Why Omega Healthcare Will Have a Healthy 2013 originally appeared on Fool.com.

Fool contributor Brian Pacampara has no positions in the stocks mentioned above. The Motley Fool has no positions in the stocks mentioned above. Try any of our Foolish newsletter services free for 30 days. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy.

Copyright © 1995 - 2013 The Motley Fool, LLC. All rights reserved. The Motley Fool has a disclosure policy.

Advertisement